The learning curve associated with the introduction of the subcutaneous implantable defibrillator
暂无分享,去创建一个
Pier D. Lambiase | Petr Neuzil | Dominic A. Theuns | P. Lambiase | P. Neužil | R. Weiss | A. Grace | A. León | D. Theuns | Paul W. Jones | L. Boersma | T. Brouwer | R. Knops | M. Burke | L. O. Olde Nordkamp | M. Hood | Andrew A. Grace | Martin C. Burke | Angel R. Leon | Lucas Boersma | Raul Weiss | Nicholas Wold | N. Wold | Marcoen Scholten | Margaret Hood | C. Barr | Reinoud E. Knops | Craig S. Barr | Tom F. Brouwer | Louise R.A. Olde Nordkamp | M. Scholten | P. Jones
[1] Eugene Crystal,et al. Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database , 2011, Circulation. Arrhythmia and electrophysiology.
[2] L. Jordaens,et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.
[3] D. Wennberg,et al. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. , 2005, Journal of the American College of Cardiology.
[4] Pier D. Lambiase,et al. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.
[5] P. Lambiase,et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.
[6] H. Krumholz,et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. , 2009, JAMA.
[7] W. Lewis,et al. Learning curves in surgical practice , 2007, Postgraduate Medical Journal.
[8] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[9] M. Gold,et al. A New Algorithm to Reduce Inappropriate Therapy in the S‐ICD System , 2015, Journal of cardiovascular electrophysiology.
[10] A. Wilde,et al. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. , 2013, Heart rhythm.
[11] C. Valzania,et al. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] Ellen Aagaard Nohr,et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.
[13] M. Gold,et al. Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.
[14] Alexander H Maass,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.
[15] Mark Kremers,et al. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.
[16] Arthur A M Wilde,et al. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. , 2015, International journal of cardiology.
[17] A. Wilde,et al. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. , 2014, Heart rhythm.